U.S. Chemicals Stock News

89bio (ETNB) shares have been on the move lately, with investors eyeing recent performance trends and weighing potential growth. The stock posted a 62% gain over the past month, which has turned heads in the biotech sector. See our latest analysis for 89bio. Momentum is definitely building for 89bio, with a strong 1-month share price return of 61.5% and noticeable buzz stemming from recent sector activity. That kind of move stands out even more when you consider the company’s 1-year total...

NeoVolta has been making headlines with its recently reported jump in sales, the release of new commercial and industrial energy storage solutions, and an announcement of plans to acquire key assets from Neubau Energy. These moves came after news of the company’s addition to the S&P Global BMI Index, catching the attention of investors looking for growth stories in energy storage. See our latest analysis for NeoVolta. On the heels of its index addition and those recent new product launches,...

BlackRock’s iShares Bitcoin Trust ETF has recently overtaken Deribit as the world’s largest venue for Bitcoin options trading, marking a major shift toward regulated, U.S.-based digital asset markets. This transition reflects a meaningful increase in institutional demand and signals Wall Street’s expanding influence over both spot and derivatives crypto markets. We’ll explore how IBIT’s rapid leadership in the Bitcoin options market cements its evolving role in institutional digital asset...

VisionSys AI (VSA) continues to operate at a loss, but over the past five years, the company has managed to cut its losses by an average of 30.3% per year. While its Price-to-Sales Ratio stands at 1.6x, matching the US Consumer Services industry average and notably lower than the peer group’s 5.8x, there is still no clear sign of profit growth momentum or improvement in net profit margins. Investors are left weighing a steadily improving loss profile and apparently attractive valuation...

As the U.S. stock market continues its upward trajectory, setting fresh records despite looming government shutdown concerns, investors are increasingly focused on companies with strong growth potential. In this environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company’s operations and future prospects.

As U.S. markets continue to rise, with major indices setting fresh records despite concerns over a government shutdown, investors are exploring opportunities beyond the traditional blue-chip stocks. Penny stocks, often seen as relics of past speculative trading days, still hold potential when backed by strong financials and solid business models. These smaller or newer companies can offer unique growth prospects and hidden value for those willing to explore beyond the well-trodden paths of...

Ellomay Capital (NYSEAM:ELLO) remains unprofitable, with no evidence of a positive net profit margin or high-quality past earnings, but has managed to reduce its losses by an average of 4.7% per year over the past five years. While investors may note the company's progress on trimming losses, ongoing concerns around financial stability and a premium valuation compared to the industry average may weigh on sentiment. See our full analysis for Ellomay Capital. Next, we will see how the latest...

Just because a business does not make any money, does not mean that the stock will go down. By way of example, Kodiak...

Despite an already strong run, Harrow, Inc. ( NASDAQ:HROW ) shares have been powering on, with a gain of 27% in the...

The simplest way to invest in stocks is to buy exchange traded funds. But you can do a lot better than that by buying...

Ternium S.A.'s ( NYSE:TX ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong buy right now...

To the annoyance of some shareholders, Niagen Bioscience, Inc. ( NASDAQ:NAGE ) shares are down a considerable 25% in...

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

With the business potentially at an important milestone, we thought we'd take a closer look at XOMA Royalty...

In late September 2025, Enanta Pharmaceuticals announced positive topline results from its Phase 2b trial of zelicapavir for treating respiratory syncytial virus (RSV) in high-risk adults, observing faster symptom resolution and a lower hospitalization rate despite not meeting the trial's primary endpoint. This proof-of-concept success provides the company with clear support to advance zelicapavir into Phase 3 development, potentially addressing significant unmet needs in the RSV market for...

Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...

Key Insights Significantly high institutional ownership implies Adverum Biotechnologies' stock price is sensitive to...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Nature Wood Group Limited ( NASDAQ:NWGL ) shareholders have had their patience rewarded with a 36% share price jump in...

While XPEL, Inc. ( NASDAQ:XPEL ) might not have the largest market cap around , it saw significant share price movement...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Key Insights Institutions' substantial holdings in NN implies that they have significant influence over the company's...

The market seemed underwhelmed by last week's earnings announcement from Accenture plc ( NYSE:ACN ) despite the healthy...